<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 28-year-old man makes an appointment with his general practitioner for a regular check-up. He has recently been diagnosed with asthma and was given a short-acting β2-agonist to use during acute exacerbations. He said he usually uses the medication 12 times per week. Which of the following is the most appropriate treatment in this case?? A: Inhalatory corticosteroids should replace β2-agonists., B: He should continue with current treatment., C: Long-acting β2-agonists should be added to his treatment regimen., D: Systemic corticosteroids should be added to his treatment regimen., E: He should start using a short-acting β2-agonist every day, not just when he has symptoms.,  <response>: This is a question about appropriate asthma treatment for a 28-year-old man who is using his short-acting β2-agonist 1-2 times per week. The key points are:- He has a new diagnosis of asthma - He is currently using a short-acting β2-agonist as needed, about 1-2 times per week- This is a regular check-up visit to review his asthma managementThe choices include different medication options like inhaled corticosteroids, long-acting β2-agonists, systemic corticosteroids, as well as continuing current treatment or changing frequency of short-acting β2-agonist use.To determine the best answer, I need to consider asthma treatment guidelines. For mild intermittent asthma with symptoms less than 2 times per week, short-acting β2-agonists as needed are the appropriate treatment. Inhaled corticosteroids are recommended for more persistent asthma. Long-acting β2-agonists are used in addition to inhaled corticosteroids for moderate-severe persistent asthma. Systemic corticosteroids are not maintenance therapy.B: He should continue with current treatment. 